• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor-CD74 signaling
 
  • Details
  • Full
Options
2025
Journal Article
Title

Dysregulated alveolar type 2 epithelial cell proteostasis promotes fibrogenic macrophage migration inhibitory factor-CD74 signaling

Abstract
Aberrant proteostasis in alveolar type 2 epithelial cells (AEC2s) contributes to idiopathic pulmonary fibrosis (IPF), but the role of the ubiquitin-proteasome system (UPS) is unclear. Here, we show that UPS disruption in AEC2s amplifies profibrotic signaling to macrophages through macrophage migration inhibitory factor (MIF) family proteins in several models. Modeling UPS disruption with an AEC2-specific cullin 3 (Cul3) deletion produced spontaneous fibrosis in a physiological aging mouse model and exacerbated fibrosis in the bleomycin-induced lung injury model. This was accompanied by expansion of transitional epithelial states and increased MIF and MIF-2 in lung tissue and bronchoalveolar lavage fluid (BALF) in the model. Global or conditional AEC2-specific deletions of Mif or Mif-2 attenuated fibrosis in the bleomycin-treated mouse model, as did conditional deletions of Cd74, the cognate receptor for MIF and MIF-2, in C-X3-C motif chemokine receptor 1 (Cx3cr1)-expressing and platelet factor 4 (Pf4)-expressing cells. Pharmacological inhibition of MIF attenuated fibrosis in bleomycin-treated and transforming growth factor-β1 (TGFB1) transgenic mouse models and in ex vivo human precision-cut lung slices treated with fibrotic cocktail. In study participants with IPF, BALF MIF was elevated compared with that in study participants without IPF. In participants with IPF, BALF MIF greater than 4000 picograms per milliliter was associated with increased mortality compared with participants with IPF with lower MIF. Together, these findings define a UPS-sensitive epithelial-macrophage signaling connection and identify MIF-CD74 cross-talk as a potential therapeutic target in fibrotic lung disease.
Author(s)
Kim, Sang-hun
Yale School of Medicine
Nouws, Jessica
Yale School of Medicine
Ruwisch, Jannik
Woodard, Gavitt A.
Yale School of Medicine
Cooley, Joseph C.
National Jewish Health
Khoury, Johad F.
Yale School of Medicine
Sun, Huanxing
Yale School of Medicine
Doherty, Edward
Yale School of Medicine
Piecychna, Marta
Yale School of Medicine
Manning, Edward P.
Yale School of Medicine
Kang, Minjong
Yale School of Medicine
Bruscia, Emanuela M.
Yale School of Medicine
Wei, Huanhuan
Yale School of Medicine
Zhang, Yuening
Yale School of Medicine
Yarovinsky, Timur Olegovich
Yale School of Medicine
Hwa, John
Yale School of Medicine
Zacharias, William J.
University of Cincinnati College of Medicine
Ingram, Jennifer L.
Duke University Medical Center
Lee, Chungeun
Division of Biology and Medicine
Elias, Jack Angel
Division of Biology and Medicine
Kaminski, Naftali
Yale School of Medicine
Redente, Elizabeth F.
National Jewish Health
Herzog, Erica Lyndrup
Yale School of Medicine
Prasse, Antje  
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM  
Bucala, Richard John
Yale School of Medicine
Sauler, Maor
Yale School of Medicine
Journal
Science Translational Medicine  
DOI
10.1126/scitranslmed.adr2277
Language
English
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024